Results 31 to 40 of about 1,315,640 (306)

Comparative analysis of kidney transplant costs related to recovery of renal function after the procedure

open access: yesBrazilian Journal of Nephrology, 2021
Introduction: The number of kidney transplants (KTx) is increasing in Brazil and, consequently, the costs of this procedure increase the country's health budget.
Raquel Martins e Quinino   +4 more
doaj   +2 more sources

Offshore Pharmaceutical Trials: Evidence, Economics, and Ethics

open access: yesMayo Clinic Proceedings: Innovations, Quality & Outcomes, 2018
B acked by a group of wealthy investors and an American university, a US pharmaceutical company recently flouted United States Food and Drug Administration (FDA) safety protections by testing an experimental herpes vaccine offshore. More than 20 American
Y. T. Yang   +2 more
semanticscholar   +1 more source

Cost-benefit analysis of pharmacist interventions over 36 months in a university hospital

open access: yesRevista de Saúde Pública, 2020
OBJECTIVE: To perform a cost-benefits analysis of a clinical pharmacy (CP) service implemented in a Neurology ward of a tertiary teaching hospital. METHODS: This is a cost-benefit analysis of a single arm, prospective cohort study performed at the adult
Maurilio de Souza Cazarim   +4 more
doaj   +1 more source

The Effect of Capital Structure on Financial Performance of Vietnamese Listing Pharmaceutical Enterprises

open access: yesJournal of Asian Finance, Economics and Business, 2020
This study investigates the effect of capital structure on the financial performance of pharmaceutical enterprises which are listing on Vietnam’s stock market. The study builds the regression using ROE as dependent variable and four independent variables,
C. Pham
semanticscholar   +1 more source

Development of Holistic integrative pharmacy Based on Clinical Pharmacy

open access: yesJournal of Holistic Integrative Pharmacy, 2020
[Abstract]: With advances in modern medicine, life science technologies, economics, information technologies, and the Internet, the focus of clinical pharmacy is transitioning from drug product-oriented to patient-oriented.
Xin ZHAO, Xiong LI
doaj   +1 more source

Public health insurance and pharmaceutical innovation: Evidence from China

open access: yesJournal of Development Economics, 2021
Developing countries are characterized by low levels of pharmaceutical innovation. A likely reason is their small market size, which is not because of the population size but because of low levels of income and lack of health insurance coverage.
Xuan Zhang, Huihua Nie
semanticscholar   +1 more source

Charting the Path to Increased Oil Palm Output in Ghana Beyond Area Expansion: Technology or Managerial Capacity — Which Leads the Way?

open access: yesAgribusiness, EarlyView.
ABSTRACT This study sets out to investigate the prospects for raising oil palm output in sub‐Saharan Africa, particularly Ghana, without further expansion of cropland. Given global concerns about oil palm's role in deforestation and land use change, the focus is on enhancing productivity on existing farmlands.
Jacob Asravor   +3 more
wiley   +1 more source

Pricing Dynamics in the US Hemp Market: A Vertical Price Transmission Analysis of the Hemp Value Chain

open access: yesAgribusiness, EarlyView.
ABSTRACT The US hemp market is a new and nascent industry that has been devoid of research for about half a century. This study examined the effects of exogenous shock on price at each phase of the value chain—Farm (hemp biomass), and its impact on prices at other phases of the value chain—Intermediary Processor (crude cannabidiol hemp) and Final ...
Solomon Odiase   +2 more
wiley   +1 more source

Distinct models to assess the cost-effectiveness of EGFR-tyrosine kinase inhibitors for the treatment of metastatic non-small cell lung cancer in the context of the Brazilian Unified Health Care System

open access: yesJornal Brasileiro de Pneumologia
Objective: Lung cancer is an important health problem due to its high incidence and mortality. The treatment of metastatic disease improved after the molecular pathways of cancer came to be known. However, targeted therapy is unavailable to many patients
Pedro Aguiar Jr   +3 more
doaj   +1 more source

SIMULATION TECHNOLOGIES IN THE MODELLING USERS’ BEHAVIORS IN THE PHARMACEUTICAL MARKET

open access: yesВісник Харківського національного університету імені В.Н. Каразіна: Серія Економіка, 2019
The creation of a new branch of economics – behavioural economics studying the features of decision-making, resulted in changes of a number of fundamental ideas.
Zoia Sokolovska, Irina Kapustya
doaj   +1 more source

Home - About - Disclaimer - Privacy